Combination therapy (COMB)

DRUG2 trials

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago, First Affiliated Hospital of Zhejiang University

Conditions

Anxiety, GeneralizedAnxiety, SeparationAnxiety, SocialEsophageal Squamous Cell Carcinoma (ESCC)

Phase 2

A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

Active, not recruitingNCT07142421

First Affiliated Hospital of Zhejiang UniversityEsophageal Squamous Cell Carcinoma (ESCC)

Start: 2025-08-06End: 2027-12-30Target: 35Updated: 2025-08-26

Phase 3

Partners in Caring for Anxious Youth

Active, not recruitingNCT04598230

Ann & Robert H Lurie Children's Hospital of ChicagoAnxiety, Generalized, Anxiety, Separation, Anxiety, Social

Start: 2021-02-09End: 2026-12-01Target: 468Updated: 2026-07-01